Podcasts about mygenetx

Dr. David Vigerust, Chief Science Officer of MyGenetx, joins Dr. Lisa Day to discuss genetic testing and why it is crucial for people who have been diagnosed with a mental illness. Dr. Vigerust is a strategic scientist, consultant, teacher, and inventor, particularly in the areas of infectious disease, oncology, genetics, pharmacogenetics (PGx) and immunology. Dr. Vigerust earned his BS degree from the University of Texas at El Paso in Biology and Chemistry, a MS degree in Immunology and Microbiology from Texas Tech University and his Ph.D. in Cellular and Molecular Pathology from Vanderbilt University School of Medicine. He completed postdoctoral fellowships in infectious disease first at St. Jude Children’s Research Hospital and second at Vanderbilt University Medical Center in the Department of Pediatrics. After completing his fellowships in 2009, he joined the faculty of Vanderbilt School of Medicine in the Department of Pathology, Immunology and Microbiology and was concurrently a Health Research Scientist for the U.S Department of Veterans Affairs. Dr. Vigerust currently maintains an Adjunct Assistant Professor position at Vanderbilt University Medical Center in the Department of Neurological Surgery and is Clinical Assistant Professor at the University of Maryland Eastern Shore School of Pharmacy. In 2014 he joined MyGenetx Clinical Laboratory as the Chief Scientific Officer and directs the scientific and educational missions of the lab.www.mygenetx.com

A powerful show with two of our favorite guests. Host Melanie Vann discusses with Dr. Dave Vigerust and Christina Veselak how our genetic makeup and nutrition influence our mental health. It doesn't get more informative than listening to these two share their wisdom.Christina Veselak is a licensed therapist in Denver, CO, and owner of Garden Gate Counseling. She specializes in EMDR therapy, somatic psychotherapy, amino acid therapy, and integrative nutrition for depression, anxiety, insomnia, PTSD treatment, drug and alcohol addiction, food & sugar addiction, relapse prevention, and hypoglycemia. Dr. Dave Vigerust, MS, Ph.D is the Chief Scientific Officer of MyGenetx.com (One of the fantastic organizations that sponsors Mental Health News Radio). MyGenetx is a CLIA certified and CAP accredited advanced healthcare Molecular and Clinical Laboratory. They are a primary resource for transitioning and implementing precision-guided medicine. Personalized Medicine is at the forefront of what we do. Testing people prior to initiating drug therapy to determine their likely response to different classes of drugs is a key emerging area of genetic testing.

As we join Springbrook Behavioral Health for their annual conference Converge Autism with our podcast it was important to interview Dr. Dave Vigerust, Chief Science Officer of MyGenetx. Our Program Director, Melanie Vann, is intimately familiar with Autism Spectrum Disorder. She and Dr. Vigerust discuss the latest research regarding genetics testing and how MyGenetx is playing a role in Autism Spectrum Disorder research.Dr. Vigerust is a strategic scientist, consultant, teacher, and inventor, particularly in the areas of infectious disease, oncology, genetics, pharmacogenetics (PGx) and immunology. Dr. Vigerust earned his BS degree from the University of Texas at El Paso in Biology and Chemistry, a MS degree in Immunology and Microbiology from Texas Tech University and his Ph.D. in Cellular and Molecular Pathology from Vanderbilt University School of Medicine. He completed postdoctoral fellowships in infectious disease first at St. Jude Children’s Research Hospital and second at Vanderbilt University Medical Center in the Department of Pediatrics. After completing his fellowships in 2009, he joined the faculty of Vanderbilt School of Medicine in the Department of Pathology, Immunology and Microbiology and was concurrently a Health Research Scientist for the U.S Department of Veterans Affairs. Dr. Vigerust currently maintains an Adjunct Assistant Professor position at Vanderbilt University Medical Center in the Department of Neurological Surgery and is Clinical Assistant Professor at the University of Maryland Eastern Shore School of Pharmacy. In 2014 he joined MyGenetx Clinical Laboratory as the Chief Scientific Officer and directs the scientific and educational missions of the lab.

Janelle Ali-Dinar, PhD is a rural healthcare expert and advocate with more than 15 years of senior healthcare executive experience in many key areas addressing policy initiatives, funding and operations as it relates to critical access hospitals (CAHs), rural health clinics (RHCs), Federal Qualified Health Centers (FQHC’s), Accountable Care Organizations (ACO’s) physicians, and patients. Dr. Ali-Dinar is a sought-after speaker on Capitol Hill. A former hospital CEO and regional rural strategy executive, Janelle serves on many state and federal boards addressing the needs of rural, public, minority, Tribal, refugee and international community health and healthcare access. She is also a past National Rural Health Association Rural Fellow, Rural Congress member, and Nebraska Rural Health Association president. She is currently the Nebraska DHHS Chair of The Office of Minority Health Statewide Council. She serves on the Regional Health Equity Region VII council as co-chair of Rural Health and Partnerships, The Mid Western Public Health Training Center Advisory Council and National Diabetes Advisory Council. She also serves on the RAC Monitor Editorial Board and provides weekly national podcasts and colum on healthcare, policy and issues of technology, access and delivery. Dr. Ali-Dinar is currently the VP of Population Health, Rural Health and Global Health Initiatives for MyGenetx providing population/precision health solutions in behavioural health, diabetes and cardiovascular disease. Janelle holds a master’s degree and doctorate in communications and policy and is a recent graduate in public health/ public health leadership.jalidinar@mygenetx.comDave Vigerust, Ph.D. is the Chief Science Officer of MyGenetx joins host Kristin Walker. www.mygenetx.com

Dave Vigerust, Ph.D. is the Chief Science Officer of MyGenetx. Dr. Vigerust is a strategic scientist, consultant, teacher, and inventor, particularly in the areas of infectious disease, oncology, genetics, pharmacogenetics (PGx) and immunology. Dr. Vigerust earned his BS degree from the University of Texas at El Paso in Biology and Chemistry, a MS degree in Immunology and Microbiology from Texas Tech University and his Ph.D. in Cellular and Molecular Pathology from Vanderbilt University School of Medicine. He completed postdoctoral fellowships in infectious disease first at St. Jude Children’s Research Hospital and second at Vanderbilt University Medical Center in the Department of Pediatrics. After completing his fellowships in 2009, he joined the faculty of Vanderbilt School of Medicine in the Department of Pathology, Immunology and Microbiology and was concurrently a Health Research Scientist for the U.S Department of Veterans Affairs. Dr. Vigerust currently maintains an Adjunct Assistant Professor position at Vanderbilt University Medical Center in the Department of Neurological Surgery and is Clinical Assistant Professor at the University of Maryland Eastern Shore School of Pharmacy. In 2014 he joined MyGenetx Clinical Laboratory as the Chief Scientific Officer and directs the scientific and educational missions of the lab.Dr. Vigerust’s academic and research interests focus around areas of precision medicine in cardiology, behavioral medicine, infectious disease, traumatic brain injury, neuro-oncology, neuroinflammation, and neurodegeneration. Dr. Vigerust has been widely published, including in 2016, studies in Clinical Diabetes, Future Cardiology, Future Neurology and Postgraduate Medical Journal. Dr. Vigerust was a speaker at 2016 TEDxNashville on the topic of Precision Medicine.www.mygenetx.com

Dave Vigerust, Ph.D. is the Chief Science Officer of MyGenetx. Dr. Vigerust is a strategic scientist, consultant, teacher, and inventor, particularly in the areas of infectious disease, oncology, genetics, pharmacogenetics (PGx) and immunology. Dr. Vigerust earned his BS degree from the University of Texas at El Paso in Biology and Chemistry, a MS degree in Immunology and Microbiology from Texas Tech University and his Ph.D. in Cellular and Molecular Pathology from Vanderbilt University School of Medicine. He completed postdoctoral fellowships in infectious disease first at St. Jude Children’s Research Hospital and second at Vanderbilt University Medical Center in the Department of Pediatrics. After completing his fellowships in 2009, he joined the faculty of Vanderbilt School of Medicine in the Department of Pathology, Immunology and Microbiology and was concurrently a Health Research Scientist for the U.S Department of Veterans Affairs. Dr. Vigerust currently maintains an Adjunct Assistant Professor position at Vanderbilt University Medical Center in the Department of Neurological Surgery and is Clinical Assistant Professor at the University of Maryland Eastern Shore School of Pharmacy. In 2014 he joined MyGenetx Clinical Laboratory as the Chief Scientific Officer and directs the scientific and educational missions of the lab.Dr. Vigerust’s academic and research interests focus around areas of precision medicine in cardiology, behavioral medicine, infectious disease, traumatic brain injury, neuro-oncology, neuroinflammation, and neurodegeneration. Dr. Vigerust has been widely published, including in 2016, studies in Clinical Diabetes, Future Cardiology, Future Neurology and Postgraduate Medical Journal. Dr. Vigerust was a speaker at 2016 TEDxNashville on the topic of Precision Medicine.www.mygenetx.com